StockData
PepGen Inc. logo

PepGen Inc. (PEPG) stock

PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$3.88−0.31 (-7.40%)

Close on Nov 17, 2026Market cap $268.73MP/E –Yield –

PepGen operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

PepGen's operating cash flow for the twelve months ending Jun 30, 2026 was -$69.34M. For fiscal 2025 it was -$81.64M. The highest annual figure on record is -$22.60M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$81.64M–
FY2024Dec 31, 2024-$82.37M–
FY2023Dec 31, 2023-$69.00M–
FY2022Dec 31, 2022-$59.27M–
FY2021Dec 31, 2021-$22.60M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$15.81M–
Q1 FY2026Mar 31, 2026-$18.43M–
Q4 FY2025Dec 31, 2025-$15.85M–
Q3 FY2025Sep 30, 2025-$19.26M–
Q2 FY2025Jun 30, 2025-$23.60M–
Q1 FY2025Mar 31, 2025-$22.93M–
Q4 FY2024Dec 31, 2024-$19.48M–
Q3 FY2024Sep 30, 2024-$24.01M–
Q2 FY2024Jun 30, 2024-$16.35M–
Q1 FY2024Mar 31, 2024-$22.53M–
Q4 FY2023Dec 31, 2023-$19.42M–
Q3 FY2023Sep 30, 2023-$16.68M–
Q2 FY2023Jun 30, 2023-$17.47M–
Q1 FY2023Mar 31, 2023-$15.42M–
Q4 FY2022Dec 31, 2022-$13.39M–
Q3 FY2022Sep 30, 2022-$20.97M–
Q2 FY2022Jun 30, 2022-$12.64M–
Q1 FY2022Mar 31, 2022-$12.27M–
Q4 FY2021Dec 31, 2021-$5.99M–
Q3 FY2021Sep 30, 2021-$7.65M–
Q2 FY2021Jun 30, 2021-$6.14M–
Q1 FY2021Mar 31, 2021-$2.83M–

More PepGen figures

See a number that looks wrong?